teclistamab-cqyv 153 MG per 1.7 ML Injection

RxCUI: 2619441
RxNorm name: teclistamab-cqyv 153 MG per 1.7 ML Injection
Display name: teclistamab-cqyv 153 MG per 1.7 ML Injection
Full name: teclistamab-cqyv 153 MG per 1.7 ML Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:59

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761291	Tecvayli	teclistamab-cqyv	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TECVAYLI	TECLISTAMAB-CQYV	Janssen Biotech, Inc.	54e0f974-ccee-44ea-9254-40e9883cee1e	2026-03-10	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2619441

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
54e0f974-ccee-44ea-9254-40e9883cee1e	teclistamab-cqyv 153 MG per 1.7 ML Injection	SY	16	These highlights do not include all the information needed to use TECVAYLI safely and effectively. See full prescribing information for TECVAYLI. TECVAYLI ® (teclistamab-cqyv) injection, for subcutaneous use Initial U.S. Approval: 2022	20260310
54e0f974-ccee-44ea-9254-40e9883cee1e	teclistamab-cqyv 153 MG in 1.7 ML Injection	PSN	16	These highlights do not include all the information needed to use TECVAYLI safely and effectively. See full prescribing information for TECVAYLI. TECVAYLI ® (teclistamab-cqyv) injection, for subcutaneous use Initial U.S. Approval: 2022	20260310
54e0f974-ccee-44ea-9254-40e9883cee1e	1.7 ML teclistamab-cqyv 90 MG/ML Injection	SCD	16	These highlights do not include all the information needed to use TECVAYLI safely and effectively. See full prescribing information for TECVAYLI. TECVAYLI ® (teclistamab-cqyv) injection, for subcutaneous use Initial U.S. Approval: 2022	20260310